Correction

Antitumor Activity of Thalidomide in Refractory Multiple Myeloma

N Engl J Med 2000; 342:364February 3, 2000

Article

Antitumor Activity of Thalidomide in Refractory Multiple Myeloma (Original Article, N Engl J Med 1999:341;1565 - 1571) . On page 1565, the affiliations should have read as follows: “From the Myeloma and Transplantation Research Center, University of Arkansas for Medical Sciences, Little Rock (S.S., J.M., R.D., D.A., P.R., P.E., N.M., E.A., C.W., J.Z., B.B.); and the Laboratory of Cellular Physiology and Immunology, Rockefeller University, New York (M.D.).” Drs. Singhal and Mehta are currently affiliated with the Myeloma and Lymphoma Program, South Carolina Cancer Center, University of South Carolina.

Citing Articles (2)

Citing Articles

1. 1

   Antonio Peramo, Melanie G. Urbanchek, Sarah A. Spanninga, Laura K. Povlich, Paul Cederna, David C. Martin. (2008) In Situ Polymerization of a Conductive Polymer in Acellular Muscle Tissue Constructs. Tissue Engineering Part A 14:3, 423-432
   CrossRef

2. 2

   Bryan T. Hennessy, Deborah A. Thomas, Francis J. Giles, Hagop Kantarjian, Srdan Verstovsek. (2005) New approaches in the treatment of myelofibrosis. Cancer 103:1, 32-43
   CrossRef